Experts advising the Centers for Disease Control and Prevention on vaccines recommended that children age 5 to 11 receive the newly authorized COVID-19 booster shot from Pfizer Inc. PFE, +0.50% and BioNTech SE BNTX, +6.88%.
The panel’s 11 to 1 vote, with one abstention, on Thursday will guide the nation’s doctors, schools and local policy makers advising parents of the 28 million U.S. children in the age group.